Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||
| Cash from operating activities | -27.73%250.26M | -42.78%346.3M | -4.53%605.22M | -54.34%633.91M | 1.39B |
| Net profit before non-cash adjustment | -185.87%-188.42M | -41.54%219.41M | -38.31%375.32M | -71.22%608.37M | --2.11B |
| Total adjustment of non-cash items | 91.69%289.79M | 59.27%151.18M | 132.74%94.92M | -57.19%40.78M | --95.27M |
| -Depreciation and amortization | 15.68%63.36M | -13.05%54.78M | -5.78%63M | 0.04%66.86M | --66.83M |
| -Disposal profit | 60.16%-6.34M | -250.77%-15.91M | -311.47%-4.54M | 52.56%2.15M | --1.41M |
| -Net exchange gains and losses | 109.09%2K | -57.14%-22K | 0.00%-14K | 98.27%-14K | ---809K |
| -Other non-cash items | 107.22%232.77M | 208.00%112.33M | 229.28%36.47M | -201.33%-28.21M | --27.84M |
| Changes in working capital | 713.07%148.89M | -117.99%-24.29M | 985.55%134.98M | 98.14%-15.24M | ---820.4M |
| -Change in receivables | -86.65%-104.71M | 66.21%-56.1M | -129.74%-166.04M | 195.11%558.21M | ---586.91M |
| -Change in inventory | -186.84%-170.09M | -145.75%-59.3M | 169.01%129.61M | 52.79%-187.81M | ---397.78M |
| -Change in payables | -164.66%-35.51M | -68.87%54.93M | 146.72%176.43M | -348.84%-377.68M | --151.78M |
| -Provision for loans, leases and other losses | 1,168.99%459.2M | 819.83%36.19M | 36.85%-5.03M | -163.57%-7.96M | --12.52M |
| Dividends paid (cash flow from operating activities) | |||||
| Dividends received (cash flow from operating activities) | |||||
| Interest paid (cash flow from operating activities) | -49.61%-9.43M | 15.38%-6.3M | 7.83%-7.45M | 22.54%-8.08M | -10.43M |
| Interest received (cash flow from operating activities) | 460.00%140K | 13.64%25K | -8.33%22K | -59.32%24K | 59K |
| Tax refund paid | 49.53%-94.45M | -189.69%-187.13M | 118.55%208.65M | -687.41%-1.12B | -142.84M |
| Other operating cash inflow (outflow) | -83.42%2.96M | 331.74%17.82M | 4.13M | 0 | 0 |
| Operating cash flow | -12.44%149.48M | -78.94%170.71M | 262.48%810.56M | -140.39%-498.88M | --1.24B |
| Investing cash flow | |||||
| Net investment product transactions | -3,849.95%-150M | --4M | --0 | ---1K | --0 |
| Net changes in other investments | -1,743.07%-926.86M | 80.37%-50.29M | 11.07%-256.17M | -2,098.05%-288.06M | --14.42M |
| Investing cash flow | -2,226.38%-1.08B | 81.93%-46.29M | 11.07%-256.17M | -2,098.06%-288.06M | --14.42M |
| Financing cash flow | |||||
| Net issuance payments of debt | 1,157.78%857.1M | 50.79%-81.03M | -236.32%-164.66M | 113.80%120.8M | ---875.5M |
| Net common stock issuance | ---- | --0 | ---86K | --0 | ---- |
| Increase or decrease of lease financing | -110.09%-15.24M | 66.55%-7.25M | -15.44%-21.69M | -17.16%-18.79M | ---16.03M |
| Cash dividends paid | ---40.6M | ---- | ---- | ---- | ---- |
| Net other fund-raising expenses | ---1K | ---- | 0.00%-1K | ---1K | ---- |
| Financing cash flow | 1,007.62%801.25M | 52.65%-88.28M | -282.77%-186.44M | 111.44%102.01M | ---891.54M |
| Net cash flow | |||||
| Beginning cash position | 4.73%800.67M | 92.80%764.5M | -63.33%396.53M | 49.66%1.08B | --722.61M |
| Current changes in cash | -448.97%-126.13M | -90.18%36.14M | 153.72%367.96M | -291.31%-684.93M | --358.03M |
| Effect of exchange rate changes | -109.09%-2K | 57.14%22K | 0.00%14K | -98.27%14K | --809K |
| Cash adjustments other than cash changes | ---- | --1K | ---- | 0.00%1K | --1K |
| End cash Position | -15.75%674.54M | 4.73%800.67M | 92.80%764.5M | -63.33%396.53M | --1.08B |
| Free cash flow | -12.44%149.48M | -78.94%170.71M | 262.48%810.56M | -140.39%-498.88M | --1.24B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |